SFGP
PFE icon

Stonebridge Financial Group (Pennsylvania)’s Pfizer PFE Stock Holding History

Stonebridge Financial Group (Pennsylvania)’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$272K Buy
11,290
+178
+2% +$4.66K 0.02% 232
2026
Q1 		$312K Buy
11,112
+3,060
+38% +$81.5K 0.03% 211
2025
Q4 		$200K Buy
+8,052
New +$203K 0.02% 241
2025
Q2 		– Sell
-6,035
Closed -$153K – 728
2025
Q1 		$153K Sell
6,035
-1,256
-17% -$32.9K 0.02% 247
2024
Q4 		$193K Buy
+7,291
New +$198K 0.02% 226

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Stonebridge Financial Group (Pennsylvania)'s PFE Position: Q2 2026 in Review

Stonebridge Financial Group (Pennsylvania) increased its Pfizer (PFE) stake by 1.6% in Q2 2026, buying an estimated $4.66K and bringing the position to 11,290 shares worth $272K. The position accounts for 0.02% of the portfolio, ranked #232.

Stonebridge Financial Group (Pennsylvania) first reported a position in PFE in Q4 2024 and has held it in 5 quarters since. The position peaked at $312K in Q1 2026. 2,442 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Stonebridge Financial Group (Pennsylvania) held 11,290 shares of Pfizer worth $272K as of Q2 2026.
  • Stonebridge Financial Group (Pennsylvania) bought 178 Pfizer shares in Q2 2026, an estimated $4.66K.
  • Pfizer made up 0.02% of Stonebridge Financial Group (Pennsylvania)'s portfolio in Q2 2026, its #232 holding.
  • Stonebridge Financial Group (Pennsylvania) first reported a position in Pfizer in Q4 2024 and has held it in 5 quarters since.
  • Stonebridge Financial Group (Pennsylvania)'s Pfizer position peaked at $312K in Q1 2026.
  • 2,442 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Stonebridge Financial Group (Pennsylvania)'s 13F filing for Q2 2026, filed 6 Jul 2026.